Go back to homepage
| Boehringer Ingelheim Animal Health | |
| Financial Details | |
| Total Company Revenue in 2010 | $ 5.06 Bn |
| Revenue from Animal Health Market in 2010 | $ 0.354 Bn |
| % of revenue from Animal Health in 2010 | 6.99% |
| Segmentwise Revenue Breakup ($ Bn) | |
| Livestock Vaccines | 0.275 |
| Companion Vaccines | 0.079 |
| Number of Major Vaccines (Animal-wise) | |
| Poultry | 0 |
| Swine | 7 |
| Fish | 0 |
| Sheep | 0 |
| Cattle | 0 |
| Canine | 0 |
| Feline | 0 |
| Equine | 2 |
| Mergers and Acquisitions (2009 - 2011) | Consideration |
| Pfizer’s certain assets of Wyeth Pharmaceutical’s Fort Dodge Animal Health business | undisclosed |
| Future Focus Areas | |
| Veterinary Vaccines under trial | 0 |
| Future Focus Areas of the company in the Veterinary Vaccines Market | Vaccines for the protection of swine and cattle |
Go back to homepage